C.I.TAKIRON Past Earnings Performance
Past criteria checks 0/6
C.I.TAKIRON's earnings have been declining at an average annual rate of -20.7%, while the Chemicals industry saw earnings growing at 6.5% annually. Revenues have been declining at an average rate of 0.5% per year. C.I.TAKIRON's return on equity is 2%, and it has net margins of 1.7%.
Key information
-20.7%
Earnings growth rate
-20.7%
EPS growth rate
Chemicals Industry Growth | 6.6% |
Revenue growth rate | -0.5% |
Return on equity | 2.0% |
Net Margin | 1.7% |
Next Earnings Update | 08 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How C.I.TAKIRON makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 137,958 | 2,298 | 29,402 | 0 |
30 Sep 23 | 141,153 | 2,486 | 29,702 | 0 |
30 Jun 23 | 144,846 | 2,576 | 30,207 | 0 |
31 Mar 23 | 145,725 | 2,460 | 30,424 | 0 |
31 Dec 22 | 146,313 | 3,763 | 30,792 | 0 |
30 Sep 22 | 144,034 | 5,042 | 30,586 | 0 |
30 Jun 22 | 141,396 | 5,263 | 30,289 | 0 |
31 Mar 22 | 141,936 | 6,660 | 30,089 | 0 |
31 Dec 21 | 141,436 | 7,159 | 30,174 | 0 |
30 Sep 21 | 140,712 | 6,726 | 30,088 | 0 |
30 Jun 21 | 138,562 | 6,323 | 29,866 | 0 |
31 Mar 21 | 134,470 | 5,332 | 29,410 | 0 |
31 Dec 20 | 133,752 | 5,199 | 29,536 | 0 |
30 Sep 20 | 132,869 | 12,827 | 29,800 | 0 |
30 Jun 20 | 137,588 | 13,504 | 30,160 | 0 |
31 Mar 20 | 139,432 | 13,091 | 30,664 | 0 |
31 Dec 19 | 142,272 | 12,997 | 31,062 | 0 |
30 Sep 19 | 148,110 | 5,513 | 31,194 | 0 |
30 Jun 19 | 147,958 | 5,841 | 31,120 | 0 |
31 Mar 19 | 150,650 | 6,391 | 31,218 | 0 |
31 Dec 18 | 150,255 | 5,959 | 31,571 | 0 |
30 Sep 18 | 148,398 | 6,058 | 31,413 | 0 |
30 Jun 18 | 147,633 | 6,474 | 31,866 | 0 |
31 Mar 18 | 147,805 | 6,579 | 32,150 | 0 |
31 Dec 17 | 130,825 | 6,308 | 29,028 | 686 |
30 Sep 17 | 112,735 | 5,297 | 26,219 | 686 |
30 Jun 17 | 94,306 | 3,404 | 23,027 | 686 |
31 Mar 17 | 75,118 | 2,695 | 19,702 | 686 |
31 Dec 16 | 73,693 | 3,022 | 18,917 | 841 |
30 Sep 16 | 73,081 | 2,787 | 18,695 | 841 |
30 Jun 16 | 73,518 | 3,004 | 18,697 | 841 |
31 Mar 16 | 72,958 | 2,746 | 18,456 | 841 |
31 Dec 15 | 71,971 | 2,455 | 18,145 | 766 |
30 Sep 15 | 70,384 | 2,073 | 17,862 | 766 |
30 Jun 15 | 69,560 | 1,901 | 17,492 | 766 |
31 Mar 15 | 70,352 | 2,168 | 17,490 | 766 |
31 Dec 14 | 72,012 | 2,939 | 17,578 | 801 |
30 Sep 14 | 73,385 | 3,430 | 17,566 | 801 |
30 Jun 14 | 72,840 | 3,689 | 17,289 | 801 |
31 Mar 14 | 72,856 | 3,788 | 17,214 | 801 |
31 Dec 13 | 69,308 | 3,128 | 16,646 | 826 |
30 Sep 13 | 68,285 | 2,953 | 16,600 | 826 |
30 Jun 13 | 67,332 | 2,642 | 16,610 | 826 |
Quality Earnings: 4215 has a large one-off loss of ¥1.4B impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 4215's current net profit margins (1.7%) are lower than last year (2.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4215's earnings have declined by 20.7% per year over the past 5 years.
Accelerating Growth: 4215's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4215 had negative earnings growth (-38.9%) over the past year, making it difficult to compare to the Chemicals industry average (-0.5%).
Return on Equity
High ROE: 4215's Return on Equity (2%) is considered low.